ROP
62
-3
SE
58
8
PNR
75
4
URBN
67
5
PX
79
6
STZ
52
2
BXP
54
-3
MAC
65
3
WU
20
-2
NUE
62
-2
KMI
83
2
MCHP
41
-4
HON
70
5
BMY
64
21
NOC
56
2
KHC
9
-8
MLM
63
-4
QCOM
59
-4
PWR
72
-2
SRE
69
3
ROP
62
-3
SE
58
8
PNR
75
4
URBN
67
5
PX
79
6
STZ
52
2
BXP
54
-3
MAC
65
3
WU
20
-2
NUE
62
-2
KMI
83
2
MCHP
41
-4
HON
70
5
BMY
64
21
NOC
56
2
KHC
9
-8
MLM
63
-4
QCOM
59
-4
PWR
72
-2
SRE
69
3
Financhill
Back

Soluna Holdings 10K Form

Sell
40

SLNH
Soluna Holdings

Last Price:
4.28
Seasonality Move:
10.61%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SLNH News And Ratings

See the #1 stock for the next 7 days that we like better than SLNH

SLNH Financial Statistics

Sales & Book Value

Annual Sales: $21.07M
Cash Flow: $-8.86M
Price / Cash Flow: 0
Annual Sales: $4.66
Price / Book: 1.37

Profitability

EPS (TTM): -17.67000
Net Income (TTM): $-29.49M
Gross Margin: $5.24M
Return on Equity: -55.4%
Return on Assets: -31.29%

Soluna Holdings Earnings Forecast

Key Soluna Holdings Financial Ratios

  • The Gross Profit Margin over the past 38 years for SLNH is 24.86%.
  • The Selling, General & Administrative Expenses for SLNH have been equal to 73.06% of Gross Profit Margin.
  • The Research & Development expenses have been 250.42% of Revenue.
  • The Interest Expense is -9.41% of Operating Income.
  • The Net Earning history of SLNH is -138.62% of Total Revenues.
  • Per Share Earnings over the last 38 years have been positive in 21 years.

Soluna Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Software
Sector: Information Technology
Current Symbol: SLNH
Website: solunacomputing.com

Debt

Debt-to-Equity Ratio: 1.23
Current Ratio: 0.84
Quick Ratio: 0.4

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SLNH Technical Analysis vs Fundamental Analysis

Sell
40
Soluna Holdings (SLNH) is a Sell

Is Soluna Holdings a Buy or a Sell?

  • Soluna Holdings stock is rated a Sell
    The current Soluna Holdings [SLNH] share price is $4.16. The Score for SLNH is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.